Unravelling Structural and Metabolic Alterations in the Hippocampus and Anterior Cingulate Cortex Using Integrated MRI and MRS in Major Depressive Disorder.
Vishwa Rawat, Deepti Upadhyay, Gagan Hans, Shivam Pandey, Pratap Sharan, Uma Sharma
{"title":"Unravelling Structural and Metabolic Alterations in the Hippocampus and Anterior Cingulate Cortex Using Integrated MRI and MRS in Major Depressive Disorder.","authors":"Vishwa Rawat, Deepti Upadhyay, Gagan Hans, Shivam Pandey, Pratap Sharan, Uma Sharma","doi":"10.1002/nbm.70261","DOIUrl":null,"url":null,"abstract":"<p><p>The present study investigated structural and metabolic changes in the two brain regions of the limbic system, right hippocampus and anterior cingulate cortex (ACC), implicated in the pathophysiology of major depressive disorder (MDD). Three-dimensional-T1-weighted magnetic resonance imaging (MRI) and single-voxel in vivo magnetic resonance spectroscopy (MRS) were performed on a 3.0 T MRI in patients with MDD (n = 64) and healthy controls (HC, n = 47). The severity of depression was assessed using clinical scales (Hamilton Depression Rating Score [HDRS] and Montgomery-Åsberg Depression Rating Score [MDRS]). The automated volumetric segmentation of the T1-weighted MR images was performed using Freesurfer 7.2.0. The tissue-corrected concentration of neurochemicals was quantified using Osprey software. The relationship between hippocampal and ACC metabolite levels was examined with their volumes. Additionally, the levels of neurochemicals and volumes were correlated with the severity of depression. After adjusting for multiple comparisons using the false discovery rate (FDR), the concentration of total NAA (t-NAA, N-acetyl aspartate+ N-acetyl-aspartyl-glutamate [NAAG]), myoinositol (mI), total choline (tCho) and total creatine (tCr) were significantly reduced (p<sub>FDR</sub> < 0.05) in the hippocampus of the MDD patients. The ACC in MDD patients showed significantly higher levels of tNAA and tCr (p<sub>FDR</sub> < 0.05). Further, the volume of ACC was significantly increased in patients with MDD. Although hippocampal volume was not different between the two groups, a weak positive correlation was observed between the tCho levels and the volumes of the hippocampus and mid-ACC. Hippocampal glutamate + glutamine (Glx) levels showed a weak negative correlation with the MDRS score, whereas ACC tCho showed a negative correlation with the HDRS score. Our observations suggested that the pathophysiology of MDD is not only associated with hippocampal neurodegeneration but may also involve glial proliferation, leading to increased ACC volume. These changes might alter neurotransmission in the limbic system, contributing to the pathophysiology of depression.</p>","PeriodicalId":19309,"journal":{"name":"NMR in Biomedicine","volume":"39 4","pages":"e70261"},"PeriodicalIF":2.8000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NMR in Biomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/nbm.70261","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
The present study investigated structural and metabolic changes in the two brain regions of the limbic system, right hippocampus and anterior cingulate cortex (ACC), implicated in the pathophysiology of major depressive disorder (MDD). Three-dimensional-T1-weighted magnetic resonance imaging (MRI) and single-voxel in vivo magnetic resonance spectroscopy (MRS) were performed on a 3.0 T MRI in patients with MDD (n = 64) and healthy controls (HC, n = 47). The severity of depression was assessed using clinical scales (Hamilton Depression Rating Score [HDRS] and Montgomery-Åsberg Depression Rating Score [MDRS]). The automated volumetric segmentation of the T1-weighted MR images was performed using Freesurfer 7.2.0. The tissue-corrected concentration of neurochemicals was quantified using Osprey software. The relationship between hippocampal and ACC metabolite levels was examined with their volumes. Additionally, the levels of neurochemicals and volumes were correlated with the severity of depression. After adjusting for multiple comparisons using the false discovery rate (FDR), the concentration of total NAA (t-NAA, N-acetyl aspartate+ N-acetyl-aspartyl-glutamate [NAAG]), myoinositol (mI), total choline (tCho) and total creatine (tCr) were significantly reduced (pFDR < 0.05) in the hippocampus of the MDD patients. The ACC in MDD patients showed significantly higher levels of tNAA and tCr (pFDR < 0.05). Further, the volume of ACC was significantly increased in patients with MDD. Although hippocampal volume was not different between the two groups, a weak positive correlation was observed between the tCho levels and the volumes of the hippocampus and mid-ACC. Hippocampal glutamate + glutamine (Glx) levels showed a weak negative correlation with the MDRS score, whereas ACC tCho showed a negative correlation with the HDRS score. Our observations suggested that the pathophysiology of MDD is not only associated with hippocampal neurodegeneration but may also involve glial proliferation, leading to increased ACC volume. These changes might alter neurotransmission in the limbic system, contributing to the pathophysiology of depression.
本研究研究了大脑边缘系统的两个区域,右海马和前扣带皮层(ACC)的结构和代谢变化,涉及重度抑郁症(MDD)的病理生理。在3.0 T MRI上对MDD患者(n = 64)和健康对照组(n = 47)进行三维t1加权磁共振成像(MRI)和单体素体内磁共振波谱(MRS)检查。采用临床量表(Hamilton抑郁评定评分[HDRS]和Montgomery-Åsberg抑郁评定评分[MDRS])评定抑郁严重程度。使用Freesurfer 7.2.0对t1加权MR图像进行自动体积分割。使用Osprey软件对神经化学物质的组织校正浓度进行量化。海马和ACC代谢物水平与它们的体积之间的关系。此外,神经化学物质的水平和体积与抑郁症的严重程度有关。在使用错误发现率(FDR)调整多重比较后,总NAA (t-NAA, n -乙酰天冬氨酸+ n -乙酰天冬氨酸谷氨酸[NAAG])、肌醇(mI)、总胆碱(tCho)和总肌酸(tCr)的浓度显著降低(pFDR FDR)
期刊介绍:
NMR in Biomedicine is a journal devoted to the publication of original full-length papers, rapid communications and review articles describing the development of magnetic resonance spectroscopy or imaging methods or their use to investigate physiological, biochemical, biophysical or medical problems. Topics for submitted papers should be in one of the following general categories: (a) development of methods and instrumentation for MR of biological systems; (b) studies of normal or diseased organs, tissues or cells; (c) diagnosis or treatment of disease. Reports may cover work on patients or healthy human subjects, in vivo animal experiments, studies of isolated organs or cultured cells, analysis of tissue extracts, NMR theory, experimental techniques, or instrumentation.